Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors at ASCO Annual Meeting
Providence Gold Mines Inc. Receives Regulatory Approvals for Fundamental Transaction & The La Dama de Oro Gold Property NI 43-101 Report
